Open Access

Erratum to: fasting remnant lipoproteins can predict postprandial hyperlipidemia

  • Tomoki Nagata1, 6,
  • Daisuke Sugiyama2, 7,
  • Takako Kise1,
  • Satomi Tsuji1, 8,
  • Hideo Ohira1,
  • Itsuko Sato3,
  • Mari Yamamoto3,
  • Hitomi Kohsaka3,
  • Seiji Kawano3,
  • Shizuya Yamashita4,
  • Yuichi Ishikawa5 and
  • Yoshio Fujioka1Email author
Lipids in Health and Disease201413:68

DOI: 10.1186/1476-511X-13-68

Received: 8 April 2014

Accepted: 14 April 2014

Published: 17 April 2014

The Research to this article has been published in Lipids in Health and Disease 2012 11:146

Correction

After publication of this article [1], we noted formatting errors in Table 2. Elapsed time (h) columns at lines 25 to 43 were out of alignment and the true 8 h data were missing. The corrected version of Table 2 is below (Table 1).
Table 1

Lipid and glucose parameters for before and 1 – 8 h after loading with test meal

A. All participants

Elapsed time (h)

  

0

1

2

4

6

8

TC

(mg/dL)

182.4 ± 32.8

180.2 ± 32.8

178.2 ± 31.3

180.4 ± 30.1

184.0 ± 31.6

188.2 ± 32.5

LDL-C

(mg/dL)

98.5 ± 26.1

96.3 ± 25.5

95.6 ± 25.5

96.7 ± 24.7

99.8 ± 25.6

102.1 ± 26.2

HDL-C

(mg/dL)

70.1 ± 15.4

68.3 ± 15.4

66.2 ± 14.1

68.3 ± 15.0

70.2 ± 15.7

72.0 ± 16.0

Sd-LDL-C

(mg/dL)

22.4 ± 12.1

19.8 ± 8.8

18.8 ± 8.5

18.6 ± 7.1

18.6 ± 7.1

19.0 ± 7.0

OxLDL

(U/mL)

7.38 ± 4.96

7.04 ± 4.98

7.25 ± 5.74

7.41 ± 5.53

7.71 ± 5.41

8.38 ± 5.46

TG

(mg/dL)

69.8 ± 31.2

92.1 ± 41.0*

103.9 ± 51.4

72.9 ± 40.4

70.7 ± 34.3

53.9 ± 23.8

Non-HDL-C

(mg/dL)

112.3 ± 30.1

112.0 ± 29.9

112.0 ± 29.3

112.0 ± 28.4

113.8 ± 28.7

116.3 ± 29.4

RemL-C

(mg/dL)

3.51 ± 1.84

4.35 ± 2.11

4.29 ± 2.46

3.90 ± 2.38

3.22 ± 1.61

2.98 ± 1.40

RLP-C

(mg/dL)

3.20 ± 1.30

4.22 ± 1.91*

5.01 ± 2.42

3.88 ± 1.94

3.03 ± 1.02

2.82 ± 0.88

RLP-TG

(mg/dL)

16.3 ± 4.0

25.5 ± 14.4

32.6 ± 21.8

21.1 ± 12.3

15.8 ± 3.4

15.3 ± 2.0

ApoA-I

(mg/dL)

161.2 ± 26.6

159.8 ± 27.3

158.7 ± 25.2

160.3 ± 25.2

163.3 ± 26.4

165.7 ± 27.0

ApoA-II

(mg/dL)

37.6 ± 6.0

37.3 ± 6.2

36.8 ± 6.0

37.4 ± 5.9

37.7 ± 5.9

38.4 ± 6.1

ApoB

(mg/dL)

66.6 ± 15.3

65.7 ± 15.1

65.0 ± 14.5

66.2 ± 14.5

67.9 ± 14.8

69.3 ± 15.2

ApoC-II

(mg/dL)

3.2 ± 1.2

3.3 ± 1.2

3.3 ± 1.2

3.3 ± 1.2

3.3 ± 1.1

3.3 ± 1.1

ApoC-III

(mg/dL)

9.5 ± 2.4

9.8 ± 2.5

9.4 ± 2.3

9.2 ± 2.2

9.0 ± 2.1

9.0 ± 2.2

ApoE

(mg/dL)

4.3 ± 1.1

4.3 ± 1.1

4.3 ± 1.0

4.2 ± 1.1

4.1 ± 1.0

4.2 ± 1.1

Non-HDL-C/HDL-C

 

1.70 ± 0.73

1.75 ± 0.75

1.80 ± 0.75

1.75 ± 0.76

1.73 ± 0.74

1.72 ± 0.73

LDL-C/HDL-C

 

1.50 ± 0.60

1.50 ± 0.61

1.52 ± 0.61

1.50 ± 0.61

1.51 ± 0.60

1.50 ± 0.60

ApoB/apoA-I

 

0.43 ± 0.13

0.42 ± 0.13

0.42 ± 0.13

0.43 ± 0.13

0.43 ± 0.13

0.43 ± 0.13

Non-HDL-C/apo B

 

1.67 ± 0.10

1.69 ± 0.10

1.71 ± 0.11

1.68 ± 0.10

1.67 ± 0.10

1.67 ± 0.10

TG/apoB

 

1.06 ± 0.44

1.41 ± 0.56§

1.61 ± 0.71

1.25 ± 0.61

0.93 ± 0.40

0.79 ± 0.32

Plasma glucose

(mg/dL)

89.9 ± 5.7

96.9 ± 20.0§

87.5 ± 10.8

87.6 ± 4.9

88.1 ± 5.7

87.2 ± 5.7

Insulin

(μU/mL)

5.6 ± 2.4

42.4 ± 24.6

18.5 ± 14.1

5.0 ± 2.2

4.2 ± 2.1

3.8 ± 1.7

B. Men

TC

(mg/dL)

183.1 ± 33.8

181.4 ± 34.5

180.0 ± 33.3

182.4 ± 32.5

185.0 ± 33.2

189.5 ± 34.9

LDL-C

(mg/dL)

101.1 ± 28.2

99.0 ± 27.5

99.3 ± 27.7

99.8 ± 26.9

102.7 ± 27.8

105.3 ± 28.8

HDL-C

(mg/dL)

66.3 ± 16.7

64.7 ± 17.4

62.5 ± 15.5

65.1 ± 17.2

66.5 ± 17.4

68.3 ± 17.9

Sd-LDL-C

(mg/dL)

23.9 ± 11.0

22.2 ± 10.2

21.4 ± 9.5

20.4 ± 9.0

19.8 ± 8.0

20.6 ± 7.8

OxLDL

(U/mL)

7.98 ± 5.48

7.91 ± 5.54

8.12 ± 6.19

8.32 ± 6.11

8.70 ± 6.22

9.44 ± 6.12

TG

(mg/dL)

78.9 ± 36.0

106.3 ± 45.1

119.5 ± 58.9

94.8 ± 51.2

68.6 ± 33.7

60.2 ± 28.6

Non-HDL-C

(mg/dL)

116.8 ± 32.5

116.8 ± 32.2

117.5 ± 31.8

117.3 ± 31.1

118.5 ± 31.2

121.2 ± 32.5

RemL-C

(mg/dL)

4.08 ± 2.13

4.99 ± 2.42

5.16 ± 2.81

4.69 ± 2.80

3.67 ± 1.91

3.36 ± 1.66

RLP-C

(mg/dL)

3.62 ± 1.51

5.00 ± 2.03*

5.82 ± 2.76

4.53 ± 2.23

3.31 ± 1.13

3.04 ± 1.01

RLP-TG

(mg/dL)

17.3 ± 5.1

30.0 ± 16.7§

37.8 ± 26.2

24.7 ± 15.2

16.4 ± 4.5

15.6 ± 2.6

ApoA-I

(mg/dL)

155.7 ± 29.2

154.4 ± 29.9

154.3 ± 28.7

155.2 ± 29.0

157.9 ± 29.4

160.6 ± 30.4

ApoA-II

(mg/dL)

33.8 ± 6.7

38.7 ± 6.8

38.4 ± 6.6

38.8 ± 6.5

39.1 ± 6.7

39.8 ± 6.8

ApoB

(mg/dL)

68.8 ± 16.3

68.3 ± 16.3

67.5 ± 15.6

68.8 ± 15.8

70.5 ± 16.0

71.8 ± 16.7

ApoC-II

(mg/dL)

3.5 ± 1.1

3.6 ± 1.1

3.6 ± 1.2

3.6 ± 1.2

3.6 ± 1.1

3.5 ± 1.1

ApoC-III

(mg/dL)

9.7 ± 2.6

10.2 ± 2.8

9.8 ± 2.7

9.5 ± 2.5

9.2 ± 2.3

9.2 ± 2.4

ApoE

(mg/dL)

4.1 ± 1.1

4.1 ± 1.1

4.2 ± 1.0

4.0 ± 1.1

3.9 ± 1.0

4.0 ± 1.0

Non-HDL-C/HDL-C

 

1.90 ± 0.85

1.96 ± 0.88

2.02 ± 0.87

1.96 ± 0.89

1.94 ± 0.86

1.92 ± 0.86

LDL-C/HDL-C

 

1.64 ± 0.71

1.66 ± 0.72

1.70 ± 0.70

1.66 ± 0.72

1.67 ± 0.71

1.66 ± 0.71

ApoB/apoA-I

 

0.46 ± 0.15

0.46 ± 0.15

0.46 ± 0.15

0.46 ± 0.16

0.46 ± 0.15

0.46 ± 0.15

Non-HDL-C/apo B

 

1.69 ± 0.10

1.70 ± 0.11

1.73 ± 0.12

1.70 ± 0.11

1.67 ± 0.10

1.68 ± 0.11

TG/apoB

 

1.17 ± 0.52

1.58 ± 0.63

1.79 ± 0.84

1.41 ± 0.73

1.00 ± 0.49

0.86 ± 0.39

Plasma glucose

(mg/dL)

91.1 ± 5.9

97.7 ± 19.9

85.7 ± 9.7

89.2 ± 4.6

88.7 ± 5.9

87.7 ± 5.9

Insulin

(μU/mL)

5.0 ± 2.1

33.6 ± 13.7

11.6 ± 7.4

4.5 ± 2.0

3.8 ± 2.3

3.7 ± 1.8

C. Women

TC

(mg/dL)

181.4 ± 32.3

178.6 ± 31.3

175.7 ± 29.1

177.6 ± 27.1

182.7 ± 30.0

186.5 ± 29.6

LDL-C

(mg/dL)

95.1 ± 23.3

92.6 ± 22.6

90.6 ± 21.8

92.5 ± 21.4

95.7 ± 22.2

97.7 ± 22.1

HDL-C

(mg/dL)

75.3 ± 12.0

73.2 ± 10.9

71.3 ± 10.3

72.8 ± 10.4

75.4 ± 11.6

77.0 ± 11.6

Sd-LDL-C

(mg/dL)

20.3 ± 13.6

16.5 ± 4.9

15.3 ± 5.3

16.1 ± 4.6

16.8 ± 5.5

16.7 ± 5.2

OxLDL

(U/mL)

6.55 ± 4.15

5.86 ± 3.91

6.06 ± 4.99

6.17 ± 4.48

6.37 ± 3.83

6.92 ± 4.10

TG

(mg/dL)

57.3 ± 16.8

72.7 ± 24.6

82.6 ± 28.3||

63.7 ± 17.0

52.8 ± 12.4

45.2 ± 10.3

Non-HDL-C

(mg/dL)

106.1 ± 25.9

105.4 ± 25.8

104.4 ± 24.2

104.8 ± 23.2

107.3 ± 24.3

109.5 ± 23.9

RemL-C

(mg/dL)

2.73 ± 0.95

3.47 ± 1.16

3.11 ± 1.13

2.83 ± 0.95

2.60 ± 0.77

2.45 ± 0.69

RLP-C

(mg/dL)

2.62 ± 0.60

3.16 ± 1.06

3.90 ± 1.22

2.98 ± 0.88

2.66 ± 0.72

2.52 ± 0.54

RLP-TG

(mg/dL)

15

19.4 ± 7.0

25.5 ± 11.0

16.2 ± 2.1

15.0 ± 0.2

15

ApoA-I

(mg/dL)

168.7 ± 21.0

167.3 ± 21.8

164.8 ± 18.5

167.3 ± 17.3

170.7 ± 20.1

172.7 ± 20.3

ApoA-II

(mg/dL)

36.0 ± 4.6

35.4 ± 4.7

34.6 ± 4.4

35.3 ± 4.3

35.8 ± 4.1

36.5 ± 4.5

ApoB

(mg/dL)

63.7 ± 13.6

62.2 ± 12.9

61.5 ± 12.5

62.6 ± 12.2

64.4 ± 12.6

65.8 ± 12.4

ApoC-II

(mg/dL)

2.8 ± 1.1

2.9 ± 1.1

2.9 ± 1.1

2.9 ± 1.0

2.9 ± 1.0

2.9 ± 1.1

ApoC-III

(mg/dL)

9.1 ± 2.0

9.3 ± 2.0

8.9 ± 1.7

8.8 ± 1.6

8.6 ± 1.8

8.7 ± 1.8

ApoE

(mg/dL)

4.7 ± 1.0

4.6 ± 1.1

4.5 ± 1.1

4.5 ± 1.1

4.5 ± 1.1

4.6 ± 1.1

Non-HDL-C/HDL-C

 

1.43 ± 0.38

1.46 ± 0.40

1.48 ± 0.39

1.47 ± 0.40

1.45 ± 0.39

1.45 ± 0.37

LDL-C/HDL-C

 

1.28 ± 0.33

1.28 ± 0.33

1.29 ± 0.33

1.29 ± 0.34

1.29 ± 0.33

1.29 ± 0.32

ApoB/apoA-I

 

0.38 ± 0.08

0.37 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

0.38 ± 0.08

Non-HDL-C/apo B

 

1.66 ± 0.11

1.68 ± 0.09

1.69 ± 0.11

1.67 ± 0.08

1.66 ± 0.10

1.66 ± 0.10

TG/apoB

 

0.92 ± 0.26

1.17 ± 0.32

1.36 ± 0.40

1.04 ± 0.29

0.84 ± 0.22

0.70 ± 0.17

Plasma glucose

(mg/dL)

88.3 ± 5.2

95.8 ± 20.6

89.9 ± 12.1

85.5 ± 5.0

87.1 ± 5.1

86.5 ± 5.7

Insulin

(μU/mL)

6.5 ± 2.6

54.1 ± 31.1

27.9 ± 15.7

5.6 ± 2.4

4.8 ± 1.8

3.9 ± 1.5

Apo apolipoprotein; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; OxLDL oxidized LDL; RemL-C remnant lipoprotein cholesterol measured using “MetaboLead RemL-C”; RLP-C remnant-like particle-cholesterol measured with “JIMRO II”; RLP-TG remnant-like particle-triglycerides; Sd-LDL-C small, dense-LDL cholesterol; TC total cholesterol; TG triglycerides. TG, RemL-C, RLP-C, RLP-TG, and TG/apoB were transformed into logarithmic values. Values are expressed as means ± SD. *p < 0.05, p < 0.005, p < 0.0001, §p < 0.01, ||p < 0.001, vs. time 0 (repeated ANOVA with Dunnett’s test).

Notes

Authors’ Affiliations

(1)
Division of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University
(2)
Section of Evidence-based Laboratory Medicine, Division of Clinical Pathology and Immunology, Department of Internal Medicine Related, Kobe University Graduate School of Medicine
(3)
Department of Clinical Laboratory, Kobe University Hospital
(4)
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
(5)
Department of Internal Medicine, Kakogawa West City Hospital
(6)
Division of Clinical Laboratory, Shimane Prefectural Central Hospital
(7)
Department of Preventive Medicine and Public Health, School of Medicine, Keio University
(8)
Division of Nutrition Guidance, Kakogawa East City Hospital

References

  1. Nagata T, Sugiyama D, Kise T, Tsuji S, Ohira H, Sato I, Yamamoto M, Kohsaka H, Kawano S, Yamashita S, Ishikawa Y, Fujioka Y: Fasting remnant lipoproteins can predict postprandial hyperlipidemia. Lipids in Health and Disease. 2012, 11: 146- 10.1186/1476-511X-11-146PubMed CentralView ArticlePubMed

Copyright

© Nagata et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement